Preliminary efficacy, safety, and immunomodulatory effects of PT-112 from a phase 2 proof of concept study in patients (pts) with thymic epithelial tumors (TETs).

Bibliographic Details
Title: Preliminary efficacy, safety, and immunomodulatory effects of PT-112 from a phase 2 proof of concept study in patients (pts) with thymic epithelial tumors (TETs).
Authors: McAdams, Meredith, Swift, Shannon, Donahue, Renee N., Celades, Carolina, Tsai, Yo-Ting, Bingham, Molly, Szabo, Eva, Zhao, Chen, Sansone, Susan, Choradia, Nirmal, Shelat, Meenakshi, O'Donnell, Joseph Francis, Ames, Tyler David, Raphael, Brooke, Steinberg, Seth M., Gulley, James L., Schlom, Jeffrey, Rajan, Arun
Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe20647-e20647, 1p
Database: Supplemental Index
More Details
ISSN:0732183X
DOI:10.1200/JCO.2023.41.16_suppl.e20647
Published in:Journal of Clinical Oncology
Language:English